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Abstract
The purpose of this study was to investigate the prevalence of
herpes simplex virus (HSV) 1&2 in women screened for Chlamydia
trachomatis and/or Neisseria gonorrhoeae (CT/GC) infections.
A total of 800 vaginal swabs were tested in a dual centre
investigation, to evaluate the prevalence of HSV-1&2 in this
population. The average age of the population was
29.8  9.2 years, ranging between 14 and 66 years with a median
of 28 years. The highest prevalence of HSV-1 or HSV-2 was
observed in the youngest age groups: teenagers and adults in their
twenties had 5.26% and 4.31% prevalence, respectively.
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Introduction
Herpes simplex viruses (HSV) 1&2 are among the most
prevalent viruses found in the general population today,
especially in the USA [1]. Genital herpes can be caused by
HSV-1&2, and is responsible for oral and genital ulceration,
virally induced blindness, viral encephalitis and disseminated
infection of neonates. HSV-1 is typically transmitted during
childhood, whereas genital herpes is most commonly caused
by HSV-2 [2]. Most individuals have no or only minimal signs or
symptoms from HSV-1&2 infection. Hence the need for a
method of accurate and rapid identiﬁcation to conﬁrm a clinical
diagnosis and to initiate early treatment and counselling.
Rising prevalence and better understanding of the under-
lying health risks and public health threat posed by sexually
transmitted diseases (STDs) are at the origin of this increased
testing demand. The many asymptomatic, undiagnosed genital
herpes cases have been found to be responsible for the
majority of transmissions to susceptible partners [3], as is the
case for several other STDs. For this reason we studied the
presence of HSV-1&2 in female patients who were referred for
Chlamydia trachomatis and/or Neisseria gonorrhoeae (CT/GC)
testing by their general practitioners because of vaginal
discharge.
The participating laboratories were provided with 800
vaginal swabs suspended in BD QX swab diluent tubes (Becton
Dickinson, Sparks, MD, USA) obtained from clinical routine
settings. These specimens were intended for CT/GC routine
diagnostics (self-collected samples). None of the specimens
used for the study were from patients with a clinical suspicion
of a genital HSV infection. The specimen analyses were
performed according to the manufacturer’s instructions.
These 800 samples were divided into two groups. Group
one was biased for patients being positive for CT and/or GC
and as such these samples were pre-selected (retrospective),
excluding any negative samples over a period of 6 months. The
second group was unbiased. In this group, the daily CT/GC
samples underwent a second round of testing for HSV-1&2
(prospective), without any previous knowledge of the CT/GC
status. The samples belonging to the unbiased group were
collected consecutively over 2 weeks. All the samples were
kept at 20°C for later analysis by the conformational test at
the second laboratory. Strand displacement ampliﬁcation
(SDA) on a BD Viper system (Becton Dickinson) was used
in the ﬁrst laboratory for the direct, qualitative detection of
CT/GC and HSV-1&2 [4]. The ampliﬁed HSV targets found by
the SDA systems are glycoprotein G and glycoprotein B
(UL27, Diagenode kit) for multiplex-PCR in the second
laboratory. The multiplex PCR was performed on a 7500 Fast
Real-Time PCR System (Life Technologies, Carlsbad, CA,
USA) under the following conditions: 50°C for 2 min and 95°C
for 10 min followed by 40 cycles of 95°C for 15 s and 60°C for
60 s. Chi-square test for 2 9 2 contingency table tests was
used to determine a probable signiﬁcance between the biased
and unbiased groups.
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The patients were between 14 and 66 years of age, with a
mean of 29.8 years (SD 9.2) and a median of 28 years, with an
interquartile range of 11 (Q1 = 23, Q3 = 34). Of these
women, 17 (2.2%) tested positive for either HSV-1 or HSV-
2. The HSV positivity rate was higher in the unbiased group
that tested negative for CT/GC (n = 382) compared with the
CT/GC-positive women: respectively, 3% and 1.4% (Table 1),
with no signiﬁcant difference. The positive predictive value and
negative predictive value for combined biased and unbiased
groups are 94.11% and 99.87%, respectively. In the unbiased
group tested for CT/GC, the prevalence of HSV-1 or HSV-2
was highest in the age groups comprising teenagers and adults
in their twenties: respectively, 5.26% and 4.31% (Fig. 1).
Use of self-collected vaginal swabs implies that HSV sampling
no longer needs to be limited to the lesions and a diffuse
sampling will sufﬁce for asymptomatic stages. As it is demon-
strated in these 800 women who were totally HSV asymptom-
atic. Four disconcordant results were initially obtained between
the two testing laboratories. These four cases were HSV-2
positive by SDA but negative by PCR testing. The PCR was
initially performed without DNA extraction, and the four
discrepant PCR negative samples were subjected to DNA
extraction before detection with PCR during retesting. The
protocol used for retesting was described as above with
standard PCR conditions, supplemented by 2 min at 50°C
followed by 10 min at 95°C with a total of 40 cycles at 60°C for
1 min. This approach reduced the number of discrepant PCR
negative test results to a single sample, which probably
remained negative because of a low viral load.
Both participating laboratories also investigate Trichomonas
vaginalis (TV) in their routine testing, in a panel with CT/GC.
Both laboratories have a recorded TV prevalence <0.1%, but
these tests are always offered as a package to general
practitioners. In 2010, >100 000 patients were tested for an
STD by Dutch STD Centres for anonymous testing, according
to the National Institute for Public Health and the Environment,
RIVM (http://www.nationaalkompas.nl/gezondheid-en-ziekte/
ziekten-en-aandoeningen/infectieziekten-en-par asitaire-ziek-
ten/soa/herpes-genitalis/omvang/). A total of 692 patients were
diagnosed with genital herpes, 354 male and 337 female [5]. The
bias group in our study showed co-infection of either HSV-1 or
HSV-2 with CT/GC, although this was not the main objective of
this study. Co-infection of HSV-1&2 and TV has been shown to
be more prevalent in HPV-positive women [6]. Because genital
herpes is mostly asymptomatic, and tests are not requested by
general practitioners unless to conﬁrm a clinical diagnosis, the
presented numbers are likely to be an under-representation of
the real genital herpes prevalence in the Netherlands. We
therefore elected to study the prevalence of HSV in women
tested for CT/GC and not in a patient group where HSV testing
was requested by general practitioners. Our study suggests a
high HSV prevalence in women from their early teens toward
their thirties. The ﬁnding of a 3% HSV-1&2 infection rate in CT/
GC-negative women in our study indicates that the addition of
HSV testing to the panel for STD screening may constitute a
beneﬁcial public health strategy.
Conﬂict of Interests
The authors declare no conﬂicts of interest.
TABLE 1. Number of positive samples for herpes simplex
virus 1&2 detected by strand displacement ampliﬁcation and
PCR within the biased and unbiased groups
SDA PCR
n HSV-1 HSV-2 HSV-1 HSV-2 %
Biased
Positive CT 376 2 2 2 2 1.4
GC 38
CT/GC 18 2 2
Negative CT/GC 0
Unbiased
Positive CT 14
GC 2
CT/GC 0
Negative CT/GC 352 3 8 3 7 3.0
Total 800 5 12 5 11 2.2
The biased group is a preselected group, selected for being positive for Chlamydia
trachomatis (CT) or Neisseria gonorrhoeae (GC) or both. A total of six patients
were co-infected with either herpes simplex virus 1 (HSV-1) or HSV-2 in this
group out of 432 (1.4%). The unbiased group comprised daily routine samples for
CT/GC testing without previous knowledge on their CT/GC status. The results in
the unbiased group shows a single discrepancy between strand displacement
ampliﬁcation (SDA) and PCR testing for HSV-2, whereby 11 positive HSV-1&2
samples were detected by SDA and ten were detected by PCR out of 368 (3%).
There was no signiﬁcant difference between the pre-selected biased and the
unbiased groups. The positive predictive value for combined biased and unbiased
groups is 94.11%, with a negative predictive value of 99.87% for both groups.
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FIG. 1. Percentage of patients tested positive for HSV 1&2 per age
category in the unbiased group. The highest prevalence of HSV 1 or 2
is detected in the teenagers and twenties with 5.26% and 4.31%,
respectively.
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